How Will Rising Demand for Osteoporosis Drugs Market?

By -
Across the globe, the incidence of osteoporosis is surging rapidly, primarily because of the growing adoption of unhealthy and sedentary lifestyles and dietary habits of people, owing to the rising urbanization rate. As per the World Health Organization (WHO), over 50% of the population across the world currently reside in urban areas and this share will rise to 70% by 2050. Moreover, with increasing work hours and long working schedules, people are not finding the time to exercise and take care of their physical health. 


All these factors are responsible for the growing prevalence of osteoporosis, which is, in turn, propelling the need for osteoporosis drugs across the world. Besides this, the surging investments being made in the development and discovery of drugs that can treat osteoporosis, on account of the growing healthcare expenditure in several countries, are also fueling the expansion of the osteoporosis drugs market. 
Apart from the above-mentioned factors, the surging population of geriatric people is also fueling the demand for these drugs. According to the World Population Aging 2020 report published by the United Nations Department of Economic and Social Affairs (UNDESA), the population of people aged 65 years or above will rise from 727 million in 2020 to more than 1.5 billion by 2050. As geriatric people are highly vulnerable to bone fractures and suffer from low bone density, their soaring population is augmenting the worldwide sales of osteoporosis drugs. 
Selective estrogen receptor modulator (SERM), bisphosphonates, rank ligand inhibitor, calcitonin, and parathyroid hormone therapy are the main osteoporosis drug classes. Out of these, the usage of the bisphosphonates class drugs was found to be the highest in the world in 2015. On the other hand, in the coming years, the popularity of rank ligand class drugs is predicted to rise at the fastest pace. Geographically, the demand for osteoporosis drugs was found to be the highest in North America in 2015.
Therefore, the demand for osteoporosis drugs is certain to shoot up in the coming years, primarily because of the growing prevalence of osteoporosis and the mushrooming population of geriatric people across the world. 

Comments

Post a Comment

Popular posts from this blog

Facial Skin Ablative Treatment Market To Reach $8,394.3 Million by 2030

By -
Image
 Drivers such as the booming geriatric population, surging number of aesthetic procedures, growing awareness regarding advanced aesthetic treatments, and increasing technological advancements will facilitate the facial skin ablative treatment market growth at a CAGR of 7.8% during the forecast period (2020–2030). The market was valued at $4,134.6 million in 2019, and it is expected to reach $8,394.3 million by 2030 . With the increasing focus on improved appearances, the demand for energy-based aesthetic treatments will amplify in the coming years. The increasing awareness regarding aesthetic procedures, on account of the rising number of exhibitions, seminars, and conferences aimed at generating awareness among the general public and healthcare professionals about the developments in aesthetic and cosmetic treatments will act as a catalyst for the market growth. For example, EuroMediCom (Informa Group) organized the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in April 20
Read more

In-Vitro Fertilization (IVF) Devices and Consumables Sector to Experience Significant Growth

By -
Image
The rising prevalence of delayed pregnancy, growing awareness about in-vitro fertilization (IVF) treatment , and declining fertility rates are positively influencing the IVF devices and consumables sector. The World bank revealed that the fertility rate, from 4.7 in 1970, came down to 2.4 in 2015.  A major cause behind infertility is smoking, which reduces the chances of pregnancy by 50.0 percent. As per an Oxford Press journal, by 2025 about 7.7 million women will be diagnosed with infertility. Download Free Sample Copy of Report:  http://bit.ly/ivf-devices-and-consumables-market-b The IVF devices and consumables sector is witnessing growth due to the improving success rate of IVF procedures, which is a result of the improvements in technology. Advanced technologies help in monitoring embryos without having to remove them from incubators to select the best one for implantation, as for a single IVF procedure, many embryos are cultured. Another technique, pre-implantatio
Read more

Rising Spinal Cord Injury Volume to Drive Osseointegration Implants Market Growth

By -
Image
The osseointegration implants market is being positively influenced by the increasing volume of dental implant surgeries and trauma incidents, rising prevalence of spinal cord injuries (SCIs), growing funds for research, and improved reimbursement support for surgeries. It generated a revenue of $9.9 billion in 2017 and is expected to advance at a 4.0% CAGR during the forecast period (2018–2023). Osseointegration implants are used for the treatment of hearing loss, tooth loss, and amputees. Osteoblasts and supporting tissue migrate to the pore in which the implant is placed. Another driving factor for the osseointegration implants market is the rising number of SCIs. They generate the highest requirement for such implants amongst all osseointegration implant-treated injuries. As per the World Health Organization, the global annual incidence of SCIs is 40 to 80 cases per one million population. In the U.S., approximately 337,000 people are living with SCIs currently, and each year, 12,
Read more